PHARMACOLOGICAL ACTION OF LITHIUM IN THE PATHOGENESIS OF PSORIASIS

Citation
O. Paduart et M. Heenen, PHARMACOLOGICAL ACTION OF LITHIUM IN THE PATHOGENESIS OF PSORIASIS, EJD. European journal of dermatology, 5(5), 1995, pp. 413-415
Citations number
37
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
11671122
Volume
5
Issue
5
Year of publication
1995
Pages
413 - 415
Database
ISI
SICI code
1167-1122(1995)5:5<413:PAOLIT>2.0.ZU;2-B
Abstract
The influence of lithium on psoriasis has been demonstrated by differe nt studies. Lithium can induce a new onset or exacerbate pre-existing psoriasis. Different mechanisms are implicated in the pharmacological mode of action of lithium in relation to the onset of psoriasis. On th e molecular level, it is well established that cAMP plays a key role i n the pathogenesis of lithium-induced psoriasis. Lithium may also affe ct the protein kinase C-inositol-biphosphate pathway by an inhibition of inositol-1-phosphatase, resulting in the alteration of cellular tra nsduction signals. On the cellular level, lithium has a mitogen effect and acts by blocking cellular differentiation. It also exerts a chemo tactic action on neutrophil polymorphonuclear cells.